PubMed Health⌕ Search

Biomedical subjects

F Najarro

Publications and source records attributed to F Najarro.

4 recordsLinked to original sources

Windows through the dusty disks surrounding the youngest low-mass protostellar objects.

The formation and evolution of young low-mass stars are characterized by important processes of mass loss and accretion occurring in the innermost regions of their placentary circumstellar disks. Because of the large obscuration of these disks at optical and infrared wavelengths in the early protostellar stages (class 0 sources), they were previously detected only at radio wavelengths using interferometric techniques. We have detected with the Infrared Space Observatory the mid-infrared (mid-IR) emission associated with the class 0 protostar VLA1 in the HH1-HH2 region located in the Orion nebula. The emission arises in three wavelength windows (at 5. 3, 6.6, and 7.5 micrometers) where the absorption due to ices and silicates has a local minimum that exposes the central part of the young protostellar system to mid-IR investigations. The mid-IR emission arises from a central source with a diameter of 4 astronomical units at an averaged temperature of approximately 700 K, deeply embedded in a dense region with a visual extinction of 80 to 100 magnitudes.

Astronomical Phenomena↗

A Second Luminous Blue Variable in the Quintuplet Cluster.

H- and K-band moderate-resolution and 4 µm high-resolution spectra have been obtained for FMM 362, a bright star in the Quintuplet Cluster near the Galactic center. The spectral features in these bands closely match those of the Pistol Star, a luminous blue variable and one of the most luminous stars known. The new spectra and previously obtained photometry imply a very high luminosity for FMM 362, L>/=106 L middle dot in circle, and a temperature of 10,000-13,000 K. Based on its luminosity, temperature, photometric variability, and similarities to the Pistol Star, we conclude that FMM 362 is a luminous blue variable.

Journal Article↗

Hepatotoxicity due to lysine salt of bendazac.

BACKGROUND: The lysine salt of bendazac is a non-steroidal anti-inflammatory agent, and it is marketed exclusively for the treatment of cataracts. We report two cases of possible hepatotoxicity due to the use of bendazac lysine. METHODS: Laboratory tests, serologic tests, abdominal sonography and scan were performed to study liver disease. RESULTS: Reversible increases of the hepatic enzymes were found in both cases. Anemia was also found in one of the cases (case 1). CONCLUSIONS: Abnormal liver test results could be related to a possible liver injury attributed to the use of bendazac lysine.

Aged↗